Investing in VANRX
VanRx is an emerging technology company offering a unique aseptic processing technology for manufacturing sterile products, including injectable pharmaceuticals. This is a rapidly growing segment of the pharmaceutical industry and adds real value to all sizes of biopharmaceutical companies. We seek to become the premier technology company in this space, and have the assets and knowledge base to do so.
Investors
We are currently in partnership with Canada’s National Research Council, through the Industrial Research Assistance Program (IRAP) to further develop our revolutionary aseptic technology, and will be seeking financial partners to commercialize these assets.
For further information please contact:
Chris Procyshyn, CEO
VanRx Pharmaceuticals Inc.
Contact
